Giuseppe
Emeritus
[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]
Eurosurveillance, Volume 18, Issue 49, 05 December 2013
Rapid communications
Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013
M Murti <SUP>1</SUP>, M Krajden<SUP>2</SUP>, M Petric<SUP>2</SUP>, J Hiebert<SUP>3</SUP>, F Hemming<SUP>1</SUP>, B Hefford<SUP>4</SUP>, M Bigham<SUP>1</SUP>, P Van Buynder<SUP>1</SUP>
<SUP></SUP>
<SUP>1</SUP>Fraser Health Authority, Surrey, British Columbia, Canada ? 2 Public Health Microbiology and Reference Laboratory British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada - 3 National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada - 4 1-1400 George St., White Rock, British Columbia, Canada
________
Citation style for this article: Murti M, Krajden M, Petric M, Hiebert J, Hemming F, Hefford B, Bigham M, Van Buynder P. Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013. Euro Surveill. 2013;18(49)
ii=20649. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20649
Date of submission: 15 November 2013
________
We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster.
-
---------
Eurosurveillance, Volume 18, Issue 49, 05 December 2013
Rapid communications
Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013
M Murti <SUP>1</SUP>, M Krajden<SUP>2</SUP>, M Petric<SUP>2</SUP>, J Hiebert<SUP>3</SUP>, F Hemming<SUP>1</SUP>, B Hefford<SUP>4</SUP>, M Bigham<SUP>1</SUP>, P Van Buynder<SUP>1</SUP>
<SUP></SUP>
<SUP>1</SUP>Fraser Health Authority, Surrey, British Columbia, Canada ? 2 Public Health Microbiology and Reference Laboratory British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada - 3 National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada - 4 1-1400 George St., White Rock, British Columbia, Canada
________
Citation style for this article: Murti M, Krajden M, Petric M, Hiebert J, Hemming F, Hefford B, Bigham M, Van Buynder P. Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013. Euro Surveill. 2013;18(49)
ii=20649. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20649 Date of submission: 15 November 2013
________
We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster.
-
---------